Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2025-31165
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Cross Site Scripting in NightWolf Penetration Platform
Source: NVD (National Vulnerability Database)
Vulnerability Description
Cross-Site Scripting (XSS) vulnerability in the Logbug module of NightWolf Penetration Testing Platform 1.2.2 allows attackers to execute JavaScript through the markdown editor feature.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
在Web页面生成时对输入的转义处理不恰当(跨站脚本)
Source: NVD (National Vulnerability Database)
Vulnerability Title
NightWolf Penetration Testing Platform 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
NightWolf Penetration Testing Platform是NightWolf公司的一款开源的网络安全测试工具,专为红队和渗透测试人员设计,用于漏洞利用、权限提升和横向移动测试。 NightWolf Penetration Testing Platform 1.2.2版本存在安全漏洞,该漏洞源于Logbug模块可能通过markdown编辑器功能执行JavaScript代码。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
FPT SoftwareNightWolf Penetration Platform 1.2.2 -
II. Public POCs for CVE-2025-31165
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2025-31165
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2025-31165

No comments yet


Leave a comment